NCT05501093

Brief Summary

This study seeks to examine the impact of bariatric surgery on oral bacteria in diabetic compared to non-diabetic patients. The purpose of this research study is to examine how diabetes changes the bacteria in the mouth. This is an important question since bacterial changes may impact oral health. Participants will attend a screening and baseline visit prior to bariatric surgery and three post bariatric surgery appointments (3 weeks post, 6 months post and 1 year to 18 months post). Samples collected at each study visit include blood, plaque, and other oral samples. At the last study visit there is an optional dental cleaning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2019

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 15, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

6.3 years

First QC Date

August 12, 2022

Last Update Submit

March 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bacterial composition

    as determined by 16s rRNA community profiling

    18 months

Secondary Outcomes (2)

  • Bacterial mRNA profiling

    18 months

  • Gingival inflammation

    18 mos.

Study Arms (2)

Diabetic patients

Diabetic patients who plan to undergo bariatric surgery

Other: sample collection

Normo-glycemic (non-diabetic) patients

Non-diabetic patients who plan to undergo bariatric surgery

Other: sample collection

Interventions

Blood, plaque, and other oral samples

Diabetic patientsNormo-glycemic (non-diabetic) patients

Eligibility Criteria

Age25 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study participants will be men and women, 25-65 years old, with a Body Mass Index (BMI) of ≥35 kg/m2 who are scheduled to undergo bariatric surgery at the University of Pennsylvania or Temple University for treatment of obesity or obesity and type 2 diabetes. The total target enrollment is 130 diabetic and 104 normoglycemic subjects.

You may qualify if:

  • Men and women undergoing bariatric surgery who are 25-65 years old.
  • BMI \> 35 kg/m2.
  • Diabetic subjects: HbA1c\> 6.0% or fasting plasma glucose \>126 mg/dl).
  • Normoglycemic subjects: HbA1c\<5.75% or fasting plasma glucose \<100 mg/dl).
  • Dental criteria: Minimum of 4 posterior teeth.
  • Signed and dated informed consent form.
  • Willing to comply with all study procedures and be available for the duration of the study.

You may not qualify if:

  • Subjects diagnosed with type 1 diabetes, maturity onset diabetes of the young (MODY), or latent autoimmune diabetes in adults (LADA).
  • Women who are considering pregnancy or are currently breastfeeding.
  • Individuals with a history of chronic inflammatory or autoimmune diseases or taking medications that affect immune function or affect body weight such as chronic systemic steroids.
  • Currently smoke more than 10 cigarettes per day.
  • Periodontal treatment within 3 months of bacterial sampling.
  • Acute periodontal infection (abscess) within 1 month of bacterial sampling or abscess in teeth or adjacent teeth within 1 month of sampling.
  • Treatment with antibiotics within one month of sample collection (except as part of the surgical regimen of prophylactic antibiotic immediately prior to surgery).
  • A treatment regimen of steroids within 1 month of sample collection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Temple University

Philadelphia, Pennsylvania, 19104, United States

Location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

Oral plaque was collected with the use of a microbrush, small paper points and periopaper strips.

MeSH Terms

Interventions

Specimen Handling

Intervention Hierarchy (Ancestors)

Clinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Dana Graves, DDS, DMSc

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2022

First Posted

August 15, 2022

Study Start

March 11, 2019

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations